Concepedia
Statistics
Publications
7
Citations
294
H-Index
Active since
2019
Affiliations
Vrije Universiteit Brussel(Current)
Universitair Ziekenhuis Brussel
Joint Research Centre
Belgian Nuclear Research Centre
Yana Dekempeneer is an author at Vrije Universiteit Brussel specializing in radionuclide therapy, oncology, and medicine.
Publications per year
2019–2024
Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies
Janik Puttemans, Yana Dekempeneer, Jos Eersels et al. · Cancers · 2020 · 67 citations · Full text
Medicine, Nuclear Medicine, Oncology +17
Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior
Yana Dekempeneer, Tom Bäck, Emma Aneheim et al. · Molecular Pharmaceutics · 2019 · 62 citations · Full text
Medicine, Medicinal Chemistry, Oncology +17
Therapeutic Efficacy of <sup>213</sup>Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer
Yana Dekempeneer, Vicky Caveliers, Maarten Ooms et al. · Molecular Pharmaceutics · 2020 · 58 citations
Preclinical Evaluation of 225Ac-Labeled Single-Domain Antibody for the Treatment of HER2pos Cancer
Magdalena Rodak, Yana Dekempeneer, Maria Wojewódzka et al. · Molecular Cancer Therapeutics · 2022 · 34 citations · Full text
Medicine, Oncology, Pharmacology +17
Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein α
Yana Dekempeneer, Sam Massa, Francis Santens et al. · Journal of Nuclear Medicine · 2023 · 33 citations · Full text
1–5 of 7